Characterization of protein kinase chk1 essential for the cell cycle checkpoint after exposure of human head and neck carcinoma A253 cells to a novel topoisomerase I inhibitor BNP1350

Molecular Pharmacology

Volumn 57, Issue 3, 2000, Pages 453-459

  Yin, Ming Biao ^a   Guo, Bin ^a   Vanhoefer, Udo ^a   Azrak, Rami G ^a   Minderman, Hans ^a   Frank, Cheryl ^a   Wrzosek, Carol ^a   Slocum, Harry K ^a   Rustum, Youcef M ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLINE; DNA FRAGMENT; DNA TOPOISOMERASE INHIBITOR; KARENITECIN; PROTEIN KINASE; PROTEIN P53; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYMOLOGY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; PULSED FIELD GEL ELECTROPHORESIS;

EID: 0034093302     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.57.3.453     Document Type: Article

References (40)

1. al-Khodairy F, Fotou E, Sheldrick KS, Griffiths DJ, Lehmann AR and Carr AM (1994) Identification and characterization of new elements involved in checkpoints and feedback controls in fission yeast. Mol Biol Cell 5:147-160.
2. Avemann K, Knippers R, Koller T and Sogo JM (1988) Camptothecin, a specific inhibitor of type I DNA topoisomerase, induces DNA breakage at replication fork. Mol Cell Biol 8:3026-3034.
3. Chen AY and Liu LF (1994) DNA topoisomerases: Essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol 34:191-218.
4. Chen L, Liu TH and Walworth NC (1999) Association of chk1 with 14-3-3 proteins in stimulated by DNA damage. Genes Dev 13:675-685.
5. Dancey J and Eisenhauer EA (1996) Current perspectives on camptothecins in cancer treatment (Editorial). Br J Cancer 74:327-338.
6. Furnari B, Rhind N and Russell P (1997) Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science (Wash DC) 277:1495-1497.
7. Giaccia AJ, Shieh J, Cholon A and Brown JM (1991) Biochemical evidence for two different mechanisms for bleomycin-induced cell killing. Mutat Res 263:69-75.
8. 2 arrest and the cytotoxicity of camptothecin in human colon carcinoma cells. Cancer Res 56:4430-4437.
9. Hartwell LH and Kastan MB (1994) Cell cycle control and cancer. Science (Wash DC) 266:1821-1828.
10. Hartwell LH and Weinert T (1989) Checkpoints: Controls that ensure the order of cell cycle events. Science (Wash DC) 246:629-634.
11. Hausheer FH, Cao S, Kanter P, Haridas K, Zhao M, Murali D, Seetharamulu P, Yao S, Reddy D, Pavankumar P, Saxe J, Huang Q, Chen X, Parker A, Wu M, Martinez N and Rustum YM (1999) Karenitecins: New preclinical developments with BNP1350, a novel, potent highly lipophilic camptothecin. Proc Am Assoc Cancer Res 40:111.
12. Hsiang YH, Lihou MG and Liu LF (1989) Arrest of DNA replication by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res 49:5077-5082.
13. Husain I, Mohler JL, Seigler HF and Besterman JM (1994) Evaluation of topoisomerase I messenger RNA, protein and catalytic activity in human tumors: Demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res 54:539-546.
14. Kaufmann WK (1995) Cell cycle checkpoints and DNA repair preserve the stability of the human genome. Cancer Metastasis Rev 14:31-41.
15. Kerr JZ, Berg SL, Hausheer F and Blaney SM (1999) Karenitecins: Cytotoxicity studies in pediatric tumor cell lines. Proc Am Assoc Cancer Res 40:112.
16. 2 block induced by DNA crosslinking agents and its possible consequence. Biochem Pharmacol 37:2303-2309.
17. Li ZR, Yin MB, Arredondo MA, Schober C and Rustum YM (1994) Down-regulation of c-myc gene expression with induction of high molecular weight DNA fragments by fluorodeoxyuridine. Biochem Pharmacol 48:327-334.
18. Liu LF (1989) DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 58:351-375.
19. Lopez-Girona A, Furnari B, Mondesert O and Russell P (1999) Nuclear localization of cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature (Lond) 397: 172-175.
20. Murnane JP (1995) Cell cycle regulation in response to DNA damage in mammalian cells: A historical perspective. Cancer Metastasis Rev 14:17-29.
21. 2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J 16:545-554.
22. O'Connor PM and Kohn KW (1992) A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells. Semin Cancer Biol 3:409-416.
23. Panadero A, Yin MB, Voigt W and Rustum YM (1995) Contrasting patterns of DNA fragmentation induced by thymidylate synthase inhibitors, ZD1694 and AG-331. Oncol Res 7:73-81.
24. Paulovich AG and Hartwell LH (1995) A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage. Cell 82:841-847.
25. Piret B, Schoonbroodt S and Piette J (1999) The ATM protein is required for sustained activation of NF-κB following DNA damage. Oncogene 18:2261-2271.
26. Pommier Y (1996) Eukaryotic DNA topoisomerase I: Genome gate keeper and its intruders, camptothecins. Semin Oncol 23:3-10.
27. Pommier Y, Leteurtre F, Fesen MR, Fujimon A, Bertrand R, Solary E, Kohlhagen G and Kohn KW (1994) Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest 12:530-542.
28. Potmesil M (1994) Camptothecins: From bench research to hospital wards. Cancer Res 54:1431-1439.
29. 2 arrest in mammalian cells. Mol Cell Biochem 29:47-57.
30. Roshak A, Gilmartin A, Imburgia C, Marshall LA and Jackson JR (1999) Inhibition of the human checkpoint kinase, chk1, abrogates G2/M arrest in response to DNA damage. Proc Am Assoc Cancer Res 40:413-414.
31. Ryan AJ, Squires S, Strutt HL and Johnson RT (1991) Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in replicating DNA. Nucleic Acids Res 19:3295-3300.
32. Schwartz DC and Cantor CR (1984) Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis. Cell 37:67-75.
33. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S and Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 28:1107-1112.
34. Tsai LH, Takahashi T, Caviness VS Jr and Harlow E (1993) Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development 119:1029-1040.
35. 2 arrest: Altered regulation of p34cdc2/cyclin B. Cancer Res 52:1823-1829.
36. Walworth NC and Bernards R (1996) Rad-dependent response of the chk1-encoded protein kinase at the DNA damage checkpoint. Science (Wash DC) 271:353-356.
37. Wan S, Capasso H and Walworth NC (1999) The topoisomerase I poison camptothecin generates a chk1-dependent DNA-damage checkpoint signal in fission yeast. Yeast 15:821-828.
38. Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK and Rustum YM (1999) Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex. Exp Cell Res 247:189-199.
39. Zakian VA (1995) ATM-related genes: What do they tell us about functions of the human gene? Cell 82:685-687.
40. Zhang H, D'Arpa P and Liu LF (1990) A model for tumor cell killing by topoisomerase poisons. Cancer Cells (Cold Spring Harbor) 2:23-27.